97344 ⎘
Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
HUMANIZED ANTIBODIES AGAINST CD79B
#2HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
#3CHIMERIC NEUROTOXINS
#4IMMUNOTOXIN FOR CANCER IMMUNOTHERAPY
#5METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF
#6ENGINEERED BACTERIA AND METHODS OF USE IN TUMOR REMODELING
#7CHIMERIC NEUROTOXINS
#8CHIMERIC NEUROTOXINS
#9ANTI-CRISPR DELIVERY COMPOSITIONS AND METHODS
#10IMMUNOTOXIN-BASED TARGETED THERAPY FOR CANCER
#11AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF
#12BISPECIFIC IMMUNOTOXINS TARGETING HUMAN CD25+CCR4+ TUMORS AND REGULATORY T-CELLS
#13RECOMBINANT EXPRESSION VECTOR FOR SECRETION OF CHLOROTOXIN, AND ATTENUATED SALMONELLA STRAIN TRANSFORMED BY MEANS OF SAME
#14INSECTICIDAL CYSTEINE RICH PEPTIDE EXPRESSION IN PLANTS
#15FUSION PROTEIN COMPRISING LIGHT PROTEIN AND ANTI-FAP ANTIBODY AND USES THEREOF
#16E. COLI FOR THE PRODUCTION OF DIPHTHERIA TOXIN POLYPEPTIDES
#17ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF
#18MODIFIED VIP3 POLYPEPTIDES
#19Combination Therapies for Treating Cancer
#20CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#21METHODS AND COMPOSITIONS WITH ANTIFUNGAL ACTIVITY
#22TREATMENT OF CANCER USING A COMBINATION OF IMMUNOMODULATION AND CHECK POINT INHIBITORS
#23TCR AND PEPTIDES
#24Cancer Neoepitopes
#25Combination Treatment for Cancer
#26PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS
#27IL3Ra Antibody Conjugates and Uses Thereof
#28CONSENSUS SEQUENCE OF THE ANTIGEN TELOMERASE AND THE USE THEREOF IN PREVENTIVE AND THERAPEUTIC VACCINATION
#29Immunogenic Fusion Peptides Including FC Fragment and a Non Toxic B Subunit of AB5 Toxin
#30IGG1 FC MONOMER AND APPLICATION THEREOF
#31GENETIC CONSTRUCT FOR TRACKING AND/OR ABLATING QUIESCENT CELLS
#32BOTULINUM NEUROTOXIN BIOHYBRID
#33Magnetic chemiluminescence immunoassay kit based on bifunctional fusion protein for mycotoxins, and use thereof
#34FUSION PROTEINS FOR IMMUNOTHERAPY AGAINST CANCER AND INFECTIOUS DISEASES
#35Vaccines targeting Neisseria gonorrhoeae
#36COMBINATION THERAPIES AGAINST CANCER AND INFECTIOUS DISEASES
#37MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES
#38IMMUNOGENIC FUSION PROTEINS AGAINST CORONAVIRUS
#39DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#40Combination Therapy of Immunotoxin and Checkpoint Inhibitor
#41Anti-Abeta Therapeutic Vaccines
#42AFFINITY MOLECULES AND METHODS FOR THEIR USE
#43COMPOSITIONS AND METHODS TARGETING FILAMENTOUS BACTERIOPHAGE
#44GLYCOSYLATED COMP PILIN VARIANTS, METHODS OF MAKING AND USES THEREOF
#45RABIES VIRAL GLYCOPROTEIN COMPOSITIONS AND METHODS OF USE
#46Vaccines for the Treatment and Prevention of Zoonotic Infections
#47IL-13RALPHA2 TARGETED IMMUNOTOXINS AND METHODS OF USE
#48CELL-TARGETED CYTOTOXIC CONSTRUCTS
#49IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN
#50CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#51PD-L1-BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT SCAFFOLDS
#52CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#53Mutant lysenin pores
#54ANTI-TIM-3 ANTIBODIES AND METHODS OF USE THEREOF
#55IMMUNOGENIC FUSION PROTEINS AGAINST INFECTIOUS ANIMAL DISEASES
#56Modified Clostridial Neurotoxins as Vaccine and Conjugate Vaccine Platforms
#57Immunotoxins with albumin binding domain
#58CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#59METHODS AND COMPOSITIONS FOR ENHANCING THE POTENCY OF SUPERANTIGEN MEDIATED CANCER IMMUNOTHERAPY
#60VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF
#61Modified VIP3 polypeptides
#62ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHODS OF USE THEREOF
#63Affinity molecules and methods for their use
#64THERAPEUTIC MULTI-TARGETING CONSTRUCTS AND USES THEREOF
#65FUSION PROTEIN AND APPLICATION THEREOF
#66Compositions Comprising Polypeptides having Xylanase Activity and Polypeptides having Arabinofuronosidase Activity
#67ANTI-PEST TOXINS AND CELLS
#68FUSION PROTEIN WITH IMMUNOENHANCING ACTIVITY
#69HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
#70deficient in Lon and SulA for gene targeting
#71TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#72NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS
#73EPHA3 AND MULTI-VALENT TARGETING OF TUMORS
#74Fusion Proteins Having a Toxin and Cancer Marker, Nanoparticles, and Uses Related Thereto
#75INSECTICIDAL PEPTIDE PRODUCTION, PEPTIDE EXPRESSION IN PLANTS AND COMBINATIONS OF CYSTEINE RICH PEPTIDES
#76PROCESS FOR OBTAINING ANTIGEN-PRESENTING VESICLES (APV) THAT ENABLES THE COUPLING OF ONE OR MORE ANTIGENS
#77B*44 restricted peptides for use in immunotherapy against cancers and related methods
#78Adenovirus-Based SARS-CoV-2 Vaccine
#79NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS
#80Cancer Neoepitopes
#81SERINE PROTEASE MOLECULES AND THERAPIES
#82Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
#83ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF
#84THERAPEUTIC TREATMENT FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS USING A MONOCLONAL ANTIBODY AGAINST THE PRE-T CELL RECEPTOR
#85ENGINEERED T CELL RECEPTORS AND METHODS OF USE
#86AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF
#87IMMUNOGENIC CONJUGATE INTENDED TO INDUCE AN IMMUNE RESPONSE DIRECTED AGAINST INTERLEUKIN-6
#88NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS
#89SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS AND USES THEREOF
#90CHIMERIC CHLOROTOXIN RECEPTORS
#91CHIMERIC NEUROTOXINS
#92B*44 restricted peptides for use in immunotherapy against cancers and related methods
#93Treatment for primary amyloidosis with anti-BCMA binding protein
#94B*44 restricted peptides for use in immunotherapy against cancers and related methods
#95B*44 restricted peptides for use in immunotherapy against cancers and related methods
#96B*44 restricted peptides for use in immunotherapy against cancers and related methods
#97TARGETED MOSQUITOCIDAL TOXINS
#98CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#99CLEAVABLE PEPTIDES AND INSECTICIDAL AND NEMATICIDAL PROTEINS COMPRISING SAME
#100RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF
#101CELL-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#102METHODS OF ENGINEERING PLATELETS FOR TARGETING CIRCULATING TUMOR CELLS
#103NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#104MHC class I epitope delivering polypeptides
#105MODIFIED VIRUS-LIKE PARTICLES OF CMV
#106FUSION PROTEINS AND USES THEREOF
#107Polypeptide composition
#108DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS AND CELL-TARGETING MOLECULES COMPRISING THE SAME
#109De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals
#110Compositions and Methods for Treating Elevated Secretory Activity
#111Cell-targeted cytotoxic constructs
#112Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#113METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
#114Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#115CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#116COMPOSITIONS AND METHODS FOR TREATMENT OF DISTENTABLE TISSUES
#117NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#118NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#119NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#120NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#121NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES
#122CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN
#123Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity
#124Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
#125BISPECIFIC IMMUNOTOXINS TARGETING HUMAN CD25+CCR4+ TUMORS AND REGULATORY T-CELLS
#126METHOD OF PRODUCING A BINDER-TOXIN FUSION PROTEIN IN A PLANT CELL OR A WHOLE PLANT
#127FUSION PROTEIN WITH A TOXIN AND SCAFFOLD PROTEIN
#128Anti-IL-23 antibodies, compositions, methods and uses
#129Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#130SALMONELLA VACCINE FOR THE TREATMENT OF CORONAVIRUS
#131Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#132Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#133COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN
#134ENGINEERED BOTULINUM NEUROTOXIN
#135Tetanus toxoid and CCL3 improve DC vaccines
#136Insect toxin delivery mediated by a densovirus coat protein
#137METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES
#138Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof
#139Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#140IL3Ralpha antibodies and uses thereof
#141FUSION PROTEINS FOR IMMUNOTHERAPY AGAINST CANCER AND INFECTIOUS DISEASES
#142MACROPINOCYTOSIS IN CANCER
#143Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity
#144Mutant lysenin pores
#145Glycosylated ComP pilin variants, methods of making and uses thereof
#146Non-integrative listeria-based vaccine and method for inducing antitumor immune response
#147THERAPEUTIC INDUCTION OF TOLERANCE USING RECOMBINANT CELL SURFACE ANTIGENS
#148B*44 restricted peptides for use in immunotherapy against cancers and related methods
#149HYBRID NEUROTOXINS
#150NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#151Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#152Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ t-cell epitopes
#153Modified VIP3 polypeptides
#154De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same
#155MHC class I epitope delivering polypeptides
#156Anti-TIM-3 antibodies and methods of use thereof
#157B*44 restricted peptides for use in immunotherapy against cancers and related methods
#158Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#159immunogenic protein and composition and application thereof
#160IgG1 FC monomer and application thereof
#161CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#162NOVEL SYSTEMS FOR SCREENING INTERNALIZING ANTIBODY AND USES THEREOF
#163COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
#164Insecticidal proteins
#165Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#166Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#167Anti-CD33 and anti-CD7 combination treatment
#168CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#169Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof
#170B*44 restricted peptides for use in immunotherapy against cancers and related methods
#171Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#172Anti-abeta therapeutic vaccines
#173TRANSDUCTION BUFFER
#174Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists
#175Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity
#176PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds
#177PRODUCTION OF BOTULINUM NEUROTOXINS USING BACILLUS SYSTEMS
#178PD-L1 binding fibronectin type III domains
#179CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES
#180Botulinum Neurotoxin Biohybrid
#181AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF
#182Split-immunotoxins for boosting oncolytic virus toxicity
#183B*44 restricted peptides for use in immunotherapy against cancers and related methods
#184Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#185Anti-CD43 antibody and use thereof for cancer treatment
#186B*44 restricted peptides for use in immunotherapy against cancers and related methods
#187IL-4-fusion formulations for treatment of central nervous system (CNS) tumors
#188Modified clostridial neurotoxins as vaccines and conjugate vaccine platforms
#189Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#190Compositions and methods for treatment of pain
#191Chimeric Molecule for Targeting c-Myc in Cells
#192Multiepitope fusion antigens and vaccines and their use in treatment of enterotoxigenic diarrhea
#193EPHA3 and multi-valent targeting of tumors
#194Antibody fusion protein and related compositions for targeting cancer
#195B*44 restricted peptides for use in immunotherapy against cancers and related methods
#196B*44 restricted peptides for use in immunotherapy against cancers and related methods
#197B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS
#198Serine protease molecules and therapies
#199Multiepitope fusion antigens and vaccines and their use in treatment of enterotoxigenic diarrhea
#200Anti-TIM-3 antibodies and methods of use thereof
#201Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity
#202Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
#203Anti-TIM-3 antibodies and methods of use thereof
#204Insecticidal peptide production, peptide expression in plants and combinations of cysteine rich peptides
#205Combination treatment for cancer with anti-BCMA binding protein and proteosome inhibitor
#206Coiled coil immunoglobulin fusion proteins and compositions thereof
#207FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
#208Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#209INSECTICIDAL COMBINATIONS
#210Fusion proteins having a toxin and cancer marker, nanoparticles, and uses related thereto
#211NANOSTRUCTURED PROTEINS AND USES THEREOF
#212Method for purifying active polypeptides or immunoconjugates
#213Systems and methods for the production of diphtheria toxin polypeptides
#214Topical compositions and uses
#215HIV-1 Env fusion peptide immunogens and their use
#216Immunogenic proteins against
#217A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES
#218Immunotoxins with albumin binding domain
#219High gene expression yeast strain
#220Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
#221MODIFIED PSEUDOMONAS EXOTOXIN A
#222Ultralong complementarity determining regions and uses thereof
#223APPLICATION OF PLANT AS HOST IN EXPRESSING VACCINE OF MIDDLE EAST RESPIRATORY SYNDROME
#224Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers
#225Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
#226Modified virus-like particles of CMV
#227Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#228Anti-IL-23 antibodies, compositions, methods and uses
#229METHOD OF TREATING A BLADDER CANCER USING A CHIMERIC EGF-TARGETED BACTERIAL TOXIN
#230TCR and peptides
#231Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#232Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy
#233AGGF1 immunogenic compositions
#234B*44 restricted peptides for use in immunotherapy against cancers and related methods
#235Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy
#236Chimeric chlorotoxin receptors
#237Modified Vip3 polypeptides
#238Modified VIP3 polypeptides
#239Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#240CELL-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#241Serine protease molecules and therapies
#242Plant-produced vaccine comprising an AG2 polypeptide from coccidioides
#243Chimeric antigen receptors containing a chlorotoxin domain
#244Compositions and methods for oral delivery of therapeutic cargo
#245Botulinum neurotoxins with modified light chain specificity and methods for producing same
#246Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#247Multivalent CD20-binding molecules comprising Shiga toxin a subunit effector regions and enriched compositions thereof
#248Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertensions, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#249Peptides and combinations of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#250Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#251Modified peptides
#252IL3Ralpha antibody conjugates and uses thereof
#253Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers
#254Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#255Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins
#256Anti-abeta therapeutic vaccines
#257Desmoglein 2 antibody fusion proteins for drug delivery
#258Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof
#259Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
#260Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#261Transfected T-cells and T-cell receptors for use in immunotherapy against cancers
#262Cleavable peptides and insecticidal and nematicidal proteins comprising same
#263Serine protease molecules and therapies
#264Engineered botulinum neurotoxin
#265RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF PRODUCING THE SAME
#266Insect toxin delivery mediated by a densovirus coat protein
#267Therapeutic multi-targeting constructs and uses thereof
#268Peptibodies, compositions thereof, and methods of treating atrial fibrillation
#269Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#270Anti-IL-23 antibodies
#271Antibody fusion protein and related compositions for targeting cancer
#272Engineered botulinum neurotoxin
#273Methods for inhibiting hematopoietic tumor cells with diphtheria tokin-interleukin-3 conjugates
#274MHC Class I Epitope Delivering Polypeptides
#275Receptor targeting constructs and uses thereof
#276Botulinum neurotoxin and its derivatives
#277COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
#278SUPPRESSION OF CANCER
#279Chimeric neurotoxins
#280Pesticidal fusion protein improvements
#281Compositions comprising angiogenic factors and methods of use thereof
#282Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#283Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#284Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#285INSECTICIDAL PROTEINS
#286Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#287Botulinum toxin-human epidermal growth factor fusion protein with increased skin cell proliferation and anti-oxidation effect and cosmetic composition for regenerating skin and improving skin wrinkle comprising the same as effective component
#288Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers
#289Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers
#290Programmable drug delivery profiles of tumor-targeted bacteria
#291Conjugates enhancing total cellular accumulation
#292Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
#293THERAPEUTIC INDUCTION OF TOLERANCE USING RECOMBINANT CELL SURFACE ANTIGENS
#294Compositions comprising cupredoxins for treating cancer
#295Anti-CD43 antibody and use thereof for cancer treatment
#296Multimodal trail molecules expressed in T cells
#297Method for purifying active polypeptides or immunoconjugates
#298Cleavable peptides and insecticidal and nematicidal proteins comprising same
#299Immunogenic proteins against clostridium difficile
#300Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers